Tramadol/paracetamol controlled-release

Drug Profile

Tramadol/paracetamol controlled-release

Alternative Names: DDS-06C; Paracetamol/tramadol controlled-release; Tramadol/acetaminophen CR - Labopharm

Latest Information Update: 30 Mar 2015

Price : $50

At a glance

  • Originator Labopharm
  • Class Acetanilides; Antipyretics; Cyclohexanols; Dimethylamines; Non-opioid analgesics; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid mu receptor agonists; Prostaglandin receptor antagonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 30 Mar 2015 No recent reports on development identified - Phase-III for Pain in USA and Canada (PO)
  • 30 Mar 2015 No recent reports on development identified - Registered for Pain in Czech Republic, Iceland (Reference Member State), Ireland, Poland, Portugal, Slovakia, Slovenia and Spain (PO)
  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top